Vaxcyte Appoints John Furey to Board of Directors
July 02, 2024 08:30 ET
|
Vaxcyte, Inc.
Vaxcyte appoints John Furey to Board of Directors.
Penicillin Drug Market Is Expected To Reach a Revenue Of USD 13.4 Bn By 2033, at 3.8% CAGR: Dimension Market Research
July 01, 2024 11:48 ET
|
Dimension Market Research
New York, July 01, 2024 (GLOBE NEWSWIRE) -- Overview The global Penicillin Drug Market is predicted to reach a size of over USD 9.6 billion by 2024, and then it is expected to grow to more than USD...
Forskolin Market is Projected to Reach $1.32 Billion, Growing at a CAGR of 8.5% By 2034 | Fact. MR
July 01, 2024 07:00 ET
|
FACT.MR
Rockville, MD., July 01, 2024 (GLOBE NEWSWIRE) -- As per a newly compiled research report by Fact.MR, a market research and competitive intelligence provider, the global Forskolin Market size is...
Global Food Allergy Treatment Market Size To Worth USD 13.76 Billion By 2033 | CAGR of 9.27%
June 28, 2024 22:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , June 28, 2024 (GLOBE NEWSWIRE) -- The Global Food Allergy Treatment Market Size is to Grow from USD 5.67 Billion in 2023 to USD 13.76 Billion by 2033, at a Compound Annual...
Earth Science Tech, Inc., Reports its March 31, 2024, Annual Results, Recording Over $11.9M in Revenue
June 28, 2024 15:37 ET
|
Earth Science Tech, Inc.
Miami, FL, June 28, 2024 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares its...
Corporate Reputation of Pharma in Canada, 2023/2024: The Views of 100 Canadian Patient Groups - Fair Pricing Policies, Transparency of Pricing, and Engaging Patients in R&D Among the Lowest-Scoring Indicators
June 26, 2024 09:25 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Canada Edition - The Views of 100 Canadian Patient Groups" report has been...
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
June 26, 2024 07:45 ET
|
Agile Therapeutics, Inc.
Agile Therapeutics will combine with Insud Pharma’s US Subsidiary, Exeltis, expanding an already significant Women’s Health/contraceptive portfolio Agile Therapeutics Common Shareholders expected to...
Corporate Reputation of Pharma in 2023/2024: The Patient Perspective and Views of 2,500+ Patient Groups - Pharma Corporate Reputation Falls from COVID Highs
June 26, 2024 06:51 ET
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide" report has...
Survey Results of 830+ Patient Groups on the Pharmaceutical Industry and Environmental, Social, and Governance (ESG) Practices
June 24, 2024 11:44 ET
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World" report has been added to ...
INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific Sessions
June 22, 2024 08:00 ET
|
MannKind
INHALE-3 STUDY REVEALS POSITIVE READOUT IN HEAD-TO-HEAD COMPARISON OF INHALED INSULIN VS. USUAL CARE IN T1D; NEW DATA PRESENTED